These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8861 related articles for article (PubMed ID: 25557335)

  • 1. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.
    Pedersen G; Saermark T; Bendtzen K; Brynskov J
    Autoimmunity; 2000 Dec; 32(4):255-63. PubMed ID: 11191284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial expression of interleukin-37b in inflammatory bowel disease.
    Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
    Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.
    Takahashi K; Imaeda H; Fujimoto T; Ban H; Bamba S; Tsujikawa T; Sasaki M; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Aug; 173(2):323-31. PubMed ID: 23607908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
    Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
    Front Immunol; 2021; 12():655960. PubMed ID: 34394073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.
    Pedersen G; Saermark T; Kirkegaard T; Brynskov J
    Clin Exp Immunol; 2009 Feb; 155(2):257-65. PubMed ID: 19137636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
    Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
    Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases.
    Wallace JW; Constant DA; Nice TJ
    Front Immunol; 2021; 12():767505. PubMed ID: 34712246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 444.